PHMV ACME Symposium 10-15-25 Question Title * 1. Full Name Question Title * 2. Email Address Question Title * 3. Credit Type MD DO APP Nursing Question Title * 4. Are you affiliated with Penn Highlands Healthcare Yes No Question Title * 5. How are you attending this conference In Person Virtual Question Title * 6. Kristina Brown, DO Title: Opioid use Disorder in PregnancyObjective: Describe the pathophysiology of OUD and its specific impact on the maternal-fetal dyad, including the risks of untreated addiction versus the benefits of treatment.A 28-year-old pregnant patient at 16 weeks gestation presents to a rural clinic with a history of intravenous heroin use. She expresses a desire to stop using opioids. What is the recommended first-line treatment for OUD in this patient? Medically supervised withdrawal followed by naltrexone Initiation of buprenorphine or methadone maintenance therapy. Inpatient detoxification with clonidine and other supportive medications. Intensive outpatient counseling without pharmacotherapy. Question Title * 7. Which of the following is a key principle of a patient-centered care plan for a pregnant individual with OUD? Mandating compliance with treatment as a condition for prenatal care. Focusing solely on the pharmacological management of the addiction. Incorporating shared decision-making and addressing the patient's social determinants of health. Prioritizing the legal and child protective services aspects of the case. Question Title * 8. Ramez Altuwijri, MD Title: Addiction Medicine and Dual DiagnosisObjective: Identify at least three common psychiatric disorders that frequently co-occur with substance use disorders and explain the bidirectional relationship between substance use and mental illness, detailing how each can exacerbate the other.Which of the following is the MOST critical element in the successful management of a patient with a dual diagnosis? Treating the substance use disorder before addressing the mental health condition. An integrated treatment approach that addresses both disorders simultaneously. Focusing on psychotherapy and deferring psychopharmacology until abstinence is achieved. Allowing the patient to choose which disorder they would like to address first. Question Title * 9. A patient with bipolar disorder and alcohol use disorder is being discharged from a dual diagnosis unit. Which of the following is the most important component of their aftercare plan to reduce the risk of relapse? A prescription for a mood stabilizer and a referral to a primary care physician. A list of local Alcoholics Anonymous (AA) meetings. A comprehensive plan that includes medication management, psychotherapy, and peer support services. A recommendation to find a new psychiatrist in their community. Question Title * 10. Jing Su, DO PGY3 Title: Nicotine Cessation in Rural Primary CareObjective: Recall the "5 A's" model for treating tobacco dependence (Ask, Advise, Assess, Assist, Arrange) and explain the mechanisms of action of at least two different types of FDA-approved smoking cessation medications.A primary care provider in a rural clinic is using the "5 A's" model for a patient who smokes. After Asking about use, Advising to quit, and Assessing willingness to quit, the patient agrees to make a quit attempt. What is the next step according to the model? Arrange a follow-up appointment. Assist the patient in developing a quit plan. Ask about their previous quit attempts. Advise them of the health benefits of quitting again Question Title * 11. A 55-year-old farmer who smokes a pack of cigarettes per day wants to quit. He has a history of a heart attack 2 years ago. Which of the following is the most appropriate initial recommendation for nicotine replacement therapy (NRT)? Naltrexone in combination with the nicotine patch. Varenicline (Chantix) as a standalone therapy. A combination of the nicotine patch and a short-acting NRT like nicotine gum or lozenge. Nicotine anonymous meetings as the sole intervention. Question Title * 12. Module 1 Pre-Evaluation: https://padsmp.qualtrics.com/jfe/form/SV_4PaDp5QNwg289ca Question Title * 13. Module 2 Pre-Evaluation: https://padsmp.qualtrics.com/jfe/form/SV_9z8ZxBHx9CWO3Xg Question Title * 14. Module 3 Pre-Evaluation: https://padsmp.qualtrics.com/jfe/form/SV_eWCzhLS42VlE8Vo Done
